11:03 AM EDT, 06/03/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts fell in Monday trading, declining 0.53% to 1,420.98 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Genfit ( GNFT ) , which rose 6.9% and 6.8% respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and biotech firm BioNTech (BNTX), which were up 3.4% and 2.8% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and semiconductor company Sequans Communications (SQNS), which dropped 6.6% and 5.2% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and oil and gas company TotalEnergies (TTE), which fell 2.7% and 1.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Bicycle Therapeutics ( BCYC ) , which climbed 8.9% and 6% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Verona Pharma ( VRNA ) , which increased 4.5% and 3.6% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company GSK (GSK) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which lost 8.1% each. They were followed by construction materials supplier CRH (CRH) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which were down 3.1% and 1.8% respectively.